Register for your FREE account now and join the thousands of healthcare professionals who have depended on us for over 26 years for accurate, concise, and timely drug information.

Keep me logged in Forgot your password?

Please wait...

Please wait...

CLEAR EYES TRIPLE ACTION

Compare CLEAR EYES TRIPLE ACTION  to:
Compare
Compare

Generic Name for CLEAR EYES TRIPLE ACTION

Tetrahydrozoline HCl 0.05%, polyvinyl alcohol 0.5%, povidone 0.6%; oph soln.

Legal Classification:

OTC

Pharmacological Class for CLEAR EYES TRIPLE ACTION

Vasoconstrictor + ocular lubricant.

Manufacturer of CLEAR EYES TRIPLE ACTION

Prestige Brands, Inc.

Indications for CLEAR EYES TRIPLE ACTION

Ocular redness and dryness.

Adults and Children:

Instill 1–2 drops in affected eye(s) up to 4 times daily.

Warnings/Precautions for CLEAR EYES TRIPLE ACTION

Narrow angle glaucoma. Discontinue if eye pain, vision changes, redness or irritation persist beyond 72 hours or worsen.

Adverse Reactions for CLEAR EYES TRIPLE ACTION

Enlarged pupils, rebound ocular redness (with overuse).

How is CLEAR EYES TRIPLE ACTION supplied?

Soln—0.5oz, 1oz

Related Disease:

Dry eye~ocular lubricants
Ocular inflammation

Related Resources

S. Aureus, Enterotoxins ID'd in Atopic Keratoconjunctivitis

April 24, 2012

Staphylococcus aureus (S. aureus) and S. aureus-secreted enterotoxins (SE) are frequently found in patients with atopic keratoconjunctivitis (AKC), particularly in those with corneal ulceration.

Serious Eye Disease Linked to Bisphosphonate Use

April 03, 2012

First-time users of oral bisphosphonates have an increased risk of both uveitis and scleritis compared with nonusers.

Orphan Drug Status for Sirolimus for Non-Infectious Uveitis

November 11, 2011

Santen announced that the FDA has granted orphan drug designation for sirolimus (DE-109) for the treatment of chronic/refractory anterior non-infectious uveitis, non-infectious intermediate uveitis, non-infectious panuveitis, and non-infectious uveitis affecting the posterior segment of the eye.

Generic Elestat Launched

November 07, 2011

Perrigo announced that its partner, PharmaForce/Luitpold Pharmaceuticals, received final approval for Epinastine HCl ophthalmic solution, 0.05%, a generic version of Elestat (Inspire Pharmaceuticals).

Fera Launches Four Ophthalmic Antibiotic Ointments

August 01, 2011

Fera Pharmaceuticals announced that it has launched four ophthalmic ointments: Neo-Polycin (neomycin and polymyxin B sulfates and bacitracin zinc), Neo-Polycin HC (neomycin and polymyxin B sulfates, bacitracin zinc and hydrocortisone acetate), Polycin (bacitracin zinc and polymyxin B sulfates), and neomycin and polymyxin B sulfates with dexamethasone.

ALAMAST

Eye Disorders > Ocular allergy/inflammation

Pemirolast potassium 0.1%; oph soln; contains lauralkonium chloride.

INFLAMASE FORTE

Eye Disorders > Ocular allergy/inflammation

Prednisolone sodium phosphate 1%; oph soln; contains benzalkonium chloride.

NEO-POLYCIN HC

Eye Disorders > Ocular allergy/inflammation

Neomycin (as sulfate) 3.5mg, polymyxin B sulfate 10000 Units, bacitracin zinc 400 Units, hydrocortisone acetate 1%; per g; oph oint.

Updated: 2/21/2012

TOBRADEX

Eye Disorders > Ocular allergy/inflammation

Tobramycin 0.3%, dexamethasone 0.1%; oph. susp; contains benzalkonium chloride.

VOLTAREN OPH SOLN

Eye Disorders > Ocular allergy/inflammation

Diclofenac sodium 0.1%.

ASTELIN

Respiratory Tract > Rhinitis/rhinorrhea (intranasal products)

Adverse reactions updated.

Updated: 5/8/2012

 

ATRAPRO ANTIPRURITIC HYDROGEL

Dermatological Disorders > Pruritus and dry skin

Monograph added.

Updated: 4/25/2012

 

ATRAPRO DERMAL SPRAY

Dermatological Disorders > Pressure/neuropathic ulcers

Monograph added.

Updated: 4/24/2012

 

B-NEXA

Nutrition > Vitamins/minerals/supplements

Monograph added.

Updated: 4/30/2012

 

CETAPHIL DERMACONTROL OIL CONTROL FOAM WASH

Dermatological Disorders > Cleansers

Monograph added.

Updated: 5/10/2012

 

Eye Disorders > Ocular allergy/inflammation

ANTIHISTAMINES: Antihistamines (eg, emedastine, pheniramine, antazoline) are reversible competitive H1 receptor antagonists that block allergic responses to histamine. Ophthalmic application ...
more »

Allergic Conjunctivitis

March 09, 2012

Allergic conjunctivitis chart of prescription and over-the-counter (OTC) drugs.

Osteoporosis Treatments

May 16, 2012

Osteoporosis treatment chart.

Mood Disorder Treatments

May 16, 2012

Mood disorder treatments for bipolar disorder, major depressive disorder, treatment resistant depression, premenstrual dysphoric disorder, and others.

Antiretroviral Contraindications and Drug Interactions Chart

May 16, 2012

HIV medication contraindications and drug interactions comparison chart.

Antiretroviral Treatment Chart

May 16, 2012

Antiretroviral dosing regimen chart for HIV.

ClinicalJobAdvisor

Loading...

More Jobs

© 2012 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions